Allogeneic Stem Cell Transplantation

Allogeneic Stem Cell Transplantation: The Last Century.- Full Intensity and Reduced Intensity Allogeneic Transplantation in AML.- Allogeneic Stem Cell Transplantation for Adult Acute Lymphoblastic Leukemia (ALL).- Hematopoietic Progenitor Cell Transplantation for Treatment of Chronic Lymphocytic Leukemia.- The Role of Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Myelogenous Leukemia Patients in the Era of Tyrosine Kinase Inhibitors.- Allogeneic Transplantation for Hodgkin’s Lymphoma.- Myeloablative Allogeneic Stem Cell Transplantation for Non-Hodgkin’s Lymphoma.- Non-Hodgkin’s Lymphoma: Allogeneic Reduced Intensity Conditioning.- The Role of Allogeneic Transplantation for Multiple Myeloma in Older Adults.- Single Versus Tandem Autologous Hematopoietic Stem Cell Transplant in Multiple Myeloma.- Treatment Strategies for Follicular Center Cell Non-Hodgkin’s Lymphoma.- The Role of Transplantation in Favorable-Risk Acute Myeloid Leukemia.- Allogeneic Stem Cell Transplantation for Acute Lymphoblastic Leukaemia in Adults.- Allogeneic Transplantation for Myelodysplastic Syndromes.- Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Acute Lymphoblastic Leukemia.- Allogeneic Transplantation for the Treatment of Multiple Myeloma.- Blood Vs. Marrow Allogeneic Stem Cell Transplantation.- Hematopoietic Cell Transplantation from Partially HLA-Mismatched (HLA-Haploidentical) Related Donors.- Unrelated Donor Transplants.- Update on Umbilical Cord Blood Transplantation.- Selection of Cord Blood Unit(s) for Transplantation.- Mobilization of Hematopoietic Cells Prior to Autologous or Allogeneic Transplantation.- Natural Killer-Cell Based Treatment in Hematopoetic Stem Cell Transplantation.- Cryopreservation of Allogeneic Stem Cell Products.- Conceptsand Controversies in the Use of Novel Preparative Regimens for Allogeneic Stem Cell Transplantation.- Allogeneic Haematopoietic Stem Cell Transplantation and Natural Killer Cell Alloreactivity.- Therapeutic Potential of Mesenchymal Stem Cells in Hematopoietic Stem Cell Transplantation.- Hematopoietic Stem Cell Transplantation for Thalassemia.- Viral Infections in Hematopoietic Stem Cell Transplant Recipients.- Fungal Infections.- Immune Reconstitution and Implications for Immunotherapy Following Hematopoeitic Stem Cell Transplantation.- Acute Graft Versus Host Disease: Prophylaxis.- Chronic Graft-Versus-Host Disease.- Post-transplant Lymphoproliferative Disorder.- Psychological Care of Adult Allogeneic Transplant Patients.- Second Allogeneic Transplantation: Outcomes and Indications.- Minimal Residual Disease.- Functional Assessment Tools and Co-morbidity Scoring in Hematopoietic Progenitor Cell Transplantation.- Unique Thrombotic and Hemostatic Complications Associated with Allogeneic Hematopoietic Stem Cell Transplantation.- How Much Isolation Is Enough for Allografts?.- Monoclonal Antibodies in Allogeneic Hematopoietic Stem Cell Transplantation for Hematologic Malignancies.- Treatment of Acute Graft-vs-Host Disease.- The Importance of Non-Human Primate Models for Pre-clinical Studies in Hematopoiesis.- In Vivo Models of Allogeneic Hematopoietic Stem Cell Transplantation.- Dendritic Cells.- Augmentation of Hematopoietic Stem Cell Transplantation with Anti-cancer Vaccines.- Erratum To.